Skip to main content

Human DLL3 ELISA Kit is a single-wash 90-min SimpleStep ELISA® for the quantitative measurement of Human DLL3 in Cell Lysate samples.

Be the first to review this product! Submit a review

Images

Sandwich ELISA - Human DLL3 ELISA Kit (AB300312), expandable thumbnail
  • Sandwich ELISA - Human DLL3 ELISA Kit (AB300312), expandable thumbnail

Key facts

Detection method

Colorimetric

Sample types

Cell Lysate

Assay type

Sandwich (quantitative)

Reactive species

Human

Range

54.688 - 3500 pg/mL

Assay time

1h 30m

Sensitivity

= 42.301 pg/mL

Reactivity data

Application

sELISA

Reactivity

Reacts

Dilution info

-

Notes

-

Target data

Function

Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity).

Alternative names

What's included?

96 Tests
Components
10X Human DLL3 Capture Antibody
1 x 600 µL
10X Human DLL3 Detector Antibody
1 x 600 µL
10X Wash Buffer PT (ab206977)
1 x 20 mL
50X Cell Extraction Enhancer Solution (ab193971)
1 x 1 mL
5X Cell Extraction Buffer PTR (ab193970)
1 x 10 mL
Antibody Diluent 4BI
1 x 6 mL
Human DLL3 Lyophilized Recombinant Protein
2 x 1 Vial
Plate Seals
1 x 1 Unit
Sample Diluent NS (ab193972)
1 x 12 mL
SimpleStep Pre-Coated 96-Well Microplate (ab206978)
1 x 1 Unit
Stop Solution
1 x 12 mL
TMB Development Solution
1 x 12 mL

Recommended products

Human DLL3 ELISA Kit is a single-wash 90-min SimpleStep ELISA® for the quantitative measurement of Human DLL3 in Cell Lysate samples.

Key facts

Detection method

Colorimetric

Sample types

Cell Lysate

Assay type

Sandwich (quantitative)

Reactive species

Human

Range

54.688 - 3500 pg/mL

Assay time

1h 30m

Assay Platform

Pre-coated microplate (12 x 8 well strips)

Sensitivity

= 42.301 pg/mL

Precision

Intra assay

Sample

Extract

n

8

mean

-

SD

-

C.V.

3.1

Inter assay

Sample

Extract

n

3

mean

-

SD

-

C.V.

7

Recovery

Sample specific recovery

Sample type

Cell Lysate

Average %

= 101

Range

97 - 105 %

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

+4°C

Storage information

+4°C

Notes

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

DLL3 also known as Delta-like protein 3 is a member of the Delta/Serrate/Jagged family. This protein has a molecular mass of approximately 64 kDa. Scientists find DLL3 expression primarily in the Golgi apparatus of cells. In healthy tissues DLL3 is mostly present in the central nervous system whereas in abnormal conditions it appears in certain types of cancer cells. The detection of DLL3 expression commonly performed using IHC (immunohistochemistry) highlights its potential as a biomarker in pathological studies.

Biological function summary

DLL3 functions mainly in the modulation of the Notch signaling pathway. It does not activate this pathway but acts as an inhibitor blocking Notch ligand activation on adjacent cells. DLL3's role involves binding directly to Notch receptors altering cellular differentiation and growth processes. Despite being related to the Delta/Serrate/LAG-2 family DLL3 exhibits unique characteristics in its interactions forming part of a regulatory complex different from its family members.

Pathways

DLL3 engages importantly in the Notch signaling pathway affecting important cellular communications that regulate development and differentiation. Its interaction with proteins of the Notch family specifically the Notch receptors highlights its inhibitory role. Additionally DLL3 intersects with the Wnt signaling pathway though indirect influencing its output by modulating availability of pathway regulators.

Associated diseases and disorders

DLL3 has significant implications in cancer notably small cell lung cancer (SCLC) and neuroendocrine tumors. Researchers associate increased DLL3 expression with aggressive tumor behavior and poor prognosis. The protein also shows relevance in congenital disorders such as spondylocostal dysostosis where abnormal DLL3 function leads to vertebral segmentation defects. In these contexts DLL3 often relates to proteins involved in the disruption of normal signaling cascades impacting both tumor progression and developmental anomalies.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sandwich ELISA - Human DLL3 ELISA Kit (ab300312), expandable thumbnail

    Sandwich ELISA - Human DLL3 ELISA Kit (ab300312)

    Example of human DLL3 standard curve in 1X Cell Extraction Buffer PTR.

    Example of human DLL3 standard curve. Background-subtracted data values (mean +/- SD) are graphed.

  • Sandwich ELISA - Human DLL3 ELISA Kit (ab300312), expandable thumbnail

    Sandwich ELISA - Human DLL3 ELISA Kit (ab300312)

    Interpolated concentrations of human DLL3 in cell extract.

    Interpolated concentration of native DLL3 was measured in duplicate at different sample concentrations. Undiluted samples are 20 μg/mL TT cell extract. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). Sample dilutions are made in 1X Cell Extraction Buffer PTR.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com